SEOUL: Shares of South Korean drugmakers declined on Friday following US President Donald Trump’s threat to impose new tariffs on pharmaceuticals.
Samsung Biologics dropped 1.6%, moving away from a more than eight-month low, while SK Biopharmaceuticals slid 2.6%.
Celltrion bucked the trend by rising 1.3% after recovering from earlier losses.
The company announced on Tuesday it had paid $330 million to acquire Imclone Systems LLC from Eli Lilly in the United States.
President Trump threatened 100% duties on all imports of branded drugs starting October 1.
This measure would apply unless manufacturers have already begun construction on production facilities within the United States. – Reuters
Hence then, the article about south korean drugmaker shares fall after trump threatens new drug tariffs was published today ( ) and is available on Daily Sun ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( South Korean drugmaker shares fall after Trump threatens new drug tariffs )
Also on site :
- Drew Barrymore’s New Stoneware Dinnerware Set Brings Sweet Vintage-Inspired Cabbageware Charm to the Table
- Ukraine-Russia war latest: Zelensky vows response to Russia’s ‘terrorist attack’ as strike on mall kills 16
- Olivia Rodrigo Releases ‘Handmaid’s Tale’-Inspired Song, ‘Serena Joy,’ in a Tiny Run of CDs, With Digital Drop to Follow